← Back to Clinical Trials
Recruiting NCT07136935

NCT07136935 A Multicenter Observational Study of an Integrated Traditional Chinese and Western Medicine Care Model in Post-Acute Treatment of Frail Elderly Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07136935
Status Recruiting
Phase
Sponsor China Medical University Hospital
Condition Frail Elderly Patients
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-07-28
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Traditional Chinese Medicine treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-07-28 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Exploring the Impact and Effectiveness of an Integrated Traditional Chinese and Western Medicine Treatment Model in Post-Acute Care for Frail Older Patients.

Eligibility Criteria

Inclusion Criteria: 1. Elderly patients aged ≥75 years. 2. A history of at least one of the following conditions: Parkinson's disease, chronic obstructive pulmonary disease (COPD), mild dementia, or chronic kidney disease at stage 3 or above. 3. Hospitalized due to an acute illness (length of hospital stay \>72 hours). 4. Functional decline within one month after completion of treatment. 5. Clinical Frailty Scale (CFS) score of 5-7 (indicating moderate or greater frailty, with retained rehabilitation potential). 6. Can answer clinical questionnaires and scales. Exclusion Criteria: 1. Medically unstable (requiring intensive medical interventions, diagnostic testing, or supplemental oxygen). 2. Unable to cooperate with treatment or communication.

Contact & Investigator

Central Contact

Yu-Chen Lee

✉ 005167@tool.caaumed.org.tw

📞 886-4-22052121

Frequently Asked Questions

Who can join the NCT07136935 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Frail Elderly Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07136935 currently recruiting?

Yes, NCT07136935 is actively recruiting participants. Contact the research team at 005167@tool.caaumed.org.tw for enrollment information.

Where is the NCT07136935 trial being conducted?

This trial is being conducted at Taichung, Taiwan.

Who is sponsoring the NCT07136935 clinical trial?

NCT07136935 is sponsored by China Medical University Hospital. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology